Cargando…
Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779852/ https://www.ncbi.nlm.nih.gov/pubmed/35074508 http://dx.doi.org/10.1016/j.jinf.2022.01.023 |
| _version_ | 1784637678663237632 |
|---|---|
| author | Favresse, Julien Bayart, Jean-Louis David, Clara Dogné, Jean-Michel Douxfils, Jonathan |
| author_facet | Favresse, Julien Bayart, Jean-Louis David, Clara Dogné, Jean-Michel Douxfils, Jonathan |
| author_sort | Favresse, Julien |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8779852 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87798522022-01-24 Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity Favresse, Julien Bayart, Jean-Louis David, Clara Dogné, Jean-Michel Douxfils, Jonathan J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-04 2022-01-21 /pmc/articles/PMC8779852/ /pubmed/35074508 http://dx.doi.org/10.1016/j.jinf.2022.01.023 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Favresse, Julien Bayart, Jean-Louis David, Clara Dogné, Jean-Michel Douxfils, Jonathan Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title | Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title_full | Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title_fullStr | Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title_full_unstemmed | Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title_short | Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity |
| title_sort | nucleocapsid serum antigen determination in sars-cov-2 infected patients using the single molecule array technology and prediction of disease severity |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779852/ https://www.ncbi.nlm.nih.gov/pubmed/35074508 http://dx.doi.org/10.1016/j.jinf.2022.01.023 |
| work_keys_str_mv | AT favressejulien nucleocapsidserumantigendeterminationinsarscov2infectedpatientsusingthesinglemoleculearraytechnologyandpredictionofdiseaseseverity AT bayartjeanlouis nucleocapsidserumantigendeterminationinsarscov2infectedpatientsusingthesinglemoleculearraytechnologyandpredictionofdiseaseseverity AT davidclara nucleocapsidserumantigendeterminationinsarscov2infectedpatientsusingthesinglemoleculearraytechnologyandpredictionofdiseaseseverity AT dognejeanmichel nucleocapsidserumantigendeterminationinsarscov2infectedpatientsusingthesinglemoleculearraytechnologyandpredictionofdiseaseseverity AT douxfilsjonathan nucleocapsidserumantigendeterminationinsarscov2infectedpatientsusingthesinglemoleculearraytechnologyandpredictionofdiseaseseverity |